Megi
1 known investors
Megi is an AI platform that predicts preeclampsia risk during pregnancy before symptoms appear and monitors blood pressure and vital signs through postpartum into long-term cardiovascular care for women. It serves healthcare providers, community birth centers, FQHCs, and health plans, and operates as a spin-off from a cardiovascular disease clinic.